Topic: Market Access Strategy Workshop
Date & Time: 2023/01/30 14:00-17:00
Location: Taipei Medical University Daan Campus B2-201

The Taipei Medical University BioMed Accelerator hosts the "Market Access Strategy Workshop", and cooperates with many innovative ecosystem partners including BE Accelerator, Taiwan Venture Capital Association, Plastics Industry Development Center, and Linkou Startup Terrace, ChungHua Biomedical Industry Association, and Central Taiwan Science Park. Jowy Tani, CEO of BioMed Accelerator, introduced the TMUXBE program co-organized with BE Accelerator to help startups to introduce their products into clinical trial and then the international market. This event invited Shian-Ying Sung, Director of Human Research to share clinical research trials of TMU; Min-Huei Hsu, Director of Data Science to share integration of medical data service; Andy Chen, Aledade New Ventures Lead shared the experience in entering the US market; Peter Wang, Founder & CTO of INOPASE Inc to share the experience in entering the Japanese market. In addition, the BioMed Accelerator specially invited 5 startups, including Dentall, QTMedical, BrainNavi, BDMobile, LuminX Biotech, to share the experience of entering the international market.

Shian-Ying Sung, Director of Human Research, shared the cases of TMU's guidance and innovation. In addition, they also assisted in clinical trials of COVID-19 vaccines and rapid test kits. Min-Huei Hsu, Director of Data Science, mentioned that data plays an important role in the development of medical care. In particular, Taiwan's national insurance health database has attracted the attention of international medical teams, hoping to understand the prevalence of diseases through cooperation.

Andy Chen, Aledade New Ventures Lead in the United States, introduced that ‘Return on investment’ is a key for startups to enter the international market and a highlight for startups to be included in American insurance. W Peter Wang, Founder & CTO of INOPASE Inc in Japan, also shared the importance of establishing relationships with international consultants.

Finally, Qin-Zhang Chen, CEO of Dentall, who entered the Southeast Asian market; Yu-Ting Chen, deputy manager of QTMedical, who has rich experience in the US market; Jerry Chieh, CEO of BrainNavi, who has entered the Middle East market; Curry Huang, CEO of BDMobile, who went to the European market; and Long-Jyun Su, CEO of LuminX Biotechnology, which introduced products to Japan, shared their experience in entering the international market.


Group photo


Startups shared their experience in entering the international marke. Left: Jowy Tani, CEO of BioMed Accelerator; Curry Huang, CEO of BDMobile; Qin-Zhang Chen, CEO of Dentall; Yu-Ting Chen, deputy manager of QTMedical; Jerry Chieh, CEO of BrainNavi; Long-Jyun Su, CEO of LuminX Biotechnology. 


Discussion session